Creative Planning
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1540235
OVERLAND PARK, KS
Position in MRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,873,241
+$1,064,232 QoQ
Shares Held
300,199
+5.0% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 177 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. MRVI ranks #57 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in MRVI
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,873,241 | 300,199 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $809,009 | 285,869 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $729,186 | 224,365 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $555,972 | 193,719 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $279,634 | 116,031 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $171,454 | 77,581 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $188,253 | 34,542 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $373,476 | 44,943 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $308,322 | 43,062 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $383,838 | 44,272 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $254,309 | 38,826 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $276,100 | 27,610 | Shares | Defined | 2023-11-16 | |
| 2023-06-30 | $229,270 | 18,445 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $315,196 | 22,498 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $255,233 | 17,836 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $378,788 | 14,837 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $423,138 | 14,894 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $743,138 | 21,070 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||